Abstract
The principal initiator of coagulation, Tissue Factor (TF) has now emerged as a critical key player in oncogenic events. TF regulates tumor growth through processes such as anti-apoptosis, tumor angiogenesis and metastasis in various solid tumors such as colorectal carcinoma, glioma and breast tumors. In the last few years it has become clear that these effects are not, or partially, attributable to activation of coagulation. Rather, activation of cellular receptors, by the binary TF:FVIIa complex, the ternary TF:FVIIa:FXa complex or by thrombin, results in intracellular signaling and altered cell behaviour. In this review, the role of TF in complex with FVIIa or FVIIa:FXa as well as the role of the Tissue Factor Pathway Inhibitor in cancer will be discussed.
Keywords: MALIGNANT TUMORS, breast cancer cells, TFPI-2 expression, ANGIOGENESIS, PAR isoforms, MAP kinase
Current Genomics
Title: Emerging Insights in the Role of Tissue Factor in Cancer
Volume: 6 Issue: 6
Author(s): H. H. Versteeg
Affiliation:
Keywords: MALIGNANT TUMORS, breast cancer cells, TFPI-2 expression, ANGIOGENESIS, PAR isoforms, MAP kinase
Abstract: The principal initiator of coagulation, Tissue Factor (TF) has now emerged as a critical key player in oncogenic events. TF regulates tumor growth through processes such as anti-apoptosis, tumor angiogenesis and metastasis in various solid tumors such as colorectal carcinoma, glioma and breast tumors. In the last few years it has become clear that these effects are not, or partially, attributable to activation of coagulation. Rather, activation of cellular receptors, by the binary TF:FVIIa complex, the ternary TF:FVIIa:FXa complex or by thrombin, results in intracellular signaling and altered cell behaviour. In this review, the role of TF in complex with FVIIa or FVIIa:FXa as well as the role of the Tissue Factor Pathway Inhibitor in cancer will be discussed.
Export Options
About this article
Cite this article as:
Versteeg H. H., Emerging Insights in the Role of Tissue Factor in Cancer, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774482936
DOI https://dx.doi.org/10.2174/138920205774482936 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets
Current Cancer Drug Targets Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma
Current Medicinal Chemistry Curcumin and Curcumin-like Molecules: From Spice to Drugs
Current Medicinal Chemistry Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Current Cancer Drug Targets Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets An Overview of Targeted Alpha Therapy with <sup>225</sup>Actinium and <sup>213</sup>Bismuth
Current Radiopharmaceuticals Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
Current Pharmaceutical Design Systemic Redox Biomarkers in Neurodegenerative Diseases
Current Drug Metabolism Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Current Cancer Drug Targets Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design Reduced NGF Secretion by HT-29 Human Colon Cancer Cells Treated with a GRPR Antagonist
Protein & Peptide Letters Tumor-related Molecular Regulatory Mechanisms of Long Non-coding RNA RMST: Recent Evidence
Mini-Reviews in Medicinal Chemistry Design, Synthesis and Evaluation of Quinoline-based Small Molecule Inhibitor of STAT3
Letters in Drug Design & Discovery Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Local Gene Delivery for Cancer Therapy
Current Gene Therapy Nanotechnology and Radiopharmaceuticals: Diagnostic and Therapeutic Approaches
Current Drug Delivery Editorial (Thematic Issue: Gene Therapy for Gastrointestinal and Liver Cancers: Past Experience, Current Status and Future Perspectives)
Current Gene Therapy Genetic Risk Factors in Cerebrovascular Disorders and Cognitive Deterioration
Current Genomics